ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,881Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1006

$677K Total Retail Price of All Prescriptions

Rank: 112 out of 1006

624 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 9,044 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 655 452 1 3
LEVOTHYROXINE SODIUM 450 301 2 2
SIMVASTATIN 396 304 3 1
AMLODIPINE BESYLATE 375 329 4 4
FUROSEMIDE 371 275 5 6
HYDROCODONE-ACETAMINOPHEN 363 164 S3 6 25
OMEPRAZOLE 334 262 7 9
ATORVASTATIN CALCIUM 319 259 8 5
ATENOLOL 304 265 9 13
WARFARIN SODIUM 274 205 10 8
METOPROLOL TARTRATE 237 211 11 7
HYDROCHLOROTHIAZIDE 220 162 12 11
GABAPENTIN 202 151 13 20
METFORMIN HCL 198 125 14 10
METOPROLOL SUCCINATE 169 144 15 12
NEXIUM 156 79 16 28
ALENDRONATE SODIUM 145 96 17 29
PANTOPRAZOLE SODIUM 144 113 18 32
ZOLPIDEM TARTRATE 143 100 19 14
GLYBURIDE 143 79 R 19 65
TAMSULOSIN HCL 130 96 21 23
POTASSIUM CHLORIDE 129 93 22 30
PREDNISONE 114 90 23 33
CITALOPRAM HBR 106 71 24 24
DIOVAN 105 71 25 16
SERTRALINE HCL 104 89 26 19
ADVAIR DISKUS 103 57 27 37
CLOPIDOGREL 90 84 28 46
ESCITALOPRAM OXALATE 90 77 28 27
CYMBALTA 87 61 30 41
BENICAR 82 70 31 78
CRESTOR 78 53 32 18
PROAIR HFA 77 46 33 64
TRAZODONE HCL 75 66 34 21
TRAMADOL HCL 75 54 34 35
RANITIDINE HCL 69 29 36 63
NAPROXEN 68 0 37 121
LIDODERM 68 46 37 66
KLOR-CON M20 66 43 39 70
PRAVASTATIN SODIUM 66 32 39 15
SPIRIVA 66 51 39 48
DONEPEZIL HCL 65 65 42 17
LANSOPRAZOLE 64 30 43 141
LOVASTATIN 63 52 44 44
AZITHROMYCIN 63 47 44 39
NAMENDA 63 63 44 34
DIGOXIN 62 51 47 52
HYDROXYZINE HCL 60 36 R 48 189
FENTANYL 60 52 S2 48 74
LACTULOSE 58 26 50 104
ALLOPURINOL 58 52 50 31
DILTIAZEM 24HR CD 57 57 52 88
LIPITOR 55 50 53 47
LEVETIRACETAM 55 26 53 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 42 55 38
NYSTATIN 52 43 56 191
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 57 77
PLAVIX 51 45 57 61
LOSARTAN POTASSIUM 50 47 59 22
PAROXETINE HCL 50 36 59 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.